Lanso (Lansoprazole)

Lansoprazole works by selectively and irreversibly binding to the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This inhibition blocks the final step of acid production, leading to a marked reduction in both basal and stimulated gastric acidity.

The specific dose and duration of Lanso are determined by the prescribing healthcare professional based on the patient’s condition, severity, and response. Dosage may differ for indications such as GERD, ulcer disease, or H. pylori eradication, and should always follow the prescriber’s instructions.

Safety of lansoprazole in pregnancy and lactation has not been fully established. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Lanso. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lanso (lansoprazole) belongs to the same class as omeprazole, esomeprazole, pantoprazole and rabeprazole. All inhibit the gastric proton pump, but they differ in pharmacokinetic profiles, drug‑interaction potential and dosing frequency, which clinicians consider when selecting the most appropriate agent for a patient.

Lanso should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight, and keep it out of reach of children. Do not store in a bathroom or near a heat source.

Lanso is taken orally, usually as a tablet or capsule, with or without food unless otherwise directed by the prescriber. Swallow the dosage form whole with a glass of water and follow the timing instructions provided by the healthcare professional.

Serious but uncommon adverse reactions can include severe allergic responses such as anaphylaxis, Clostridioides difficile‑associated diarrhoea, liver enzyme elevations, low magnesium levels, and rare skin conditions like Stevens‑Johnson syndrome. Seek immediate medical attention if you experience rash, swelling, persistent diarrhoea, or muscle weakness.

Lanso is contraindicated in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking certain interacting medications, and patients with a history of low magnesium levels. The prescriber should evaluate suitability before initiating therapy.